2007;67:8131C8138
2007;67:8131C8138. these therapeutic strategies and suggest a feasible mechanism where carcinoma cells might escape from proteasome inhibitor-based therapy. EMT. Right here we present that immortalized individual mammary epithelial (HMLE) cells and MCF10A cells, both well-established model systems for EMT [6], lower their proteasome activity because they go through EMT. Strikingly, we noticed that selective inhibition…